LONDON – Pharma giants GlaxoSmithKline and Sanofi Pasteur have announced they will supply 100 million doses of its experimental COVID-19 vaccine to the United States as governments buy up supplies in hopes something will work.The United States will pay up to $2.1 billion “for development including clinical trials, manufacturing, scale-up and delivery of its vaccine,'' the companies said in a statement.